Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment.

Author: BarryDeclan T, BuonoFrank D, CutterChristopher J, FiellinDavid A, FiellinLynn E, MooreBrent A, O'ConnorPatrick G, SchottenfeldRichard S

Paper Details 
Original Abstract of the Article :
To determine whether treatment outcomes differed for prescription opioid and heroin use disorder patients, we conducted a secondary analysis of a 24-week (N=140) randomized trial of physician management (PM) or PM plus cognitive behavioral therapy (CBT) in primary care buprenorphine/naloxone treatme...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/27776678

データ提供:米国国立医学図書館(NLM)

CBT: A Guiding Oasis in the Desert of Opioid Use Disorder

The [treatment of opioid use disorder] is a complex and challenging journey. This research investigates the role of [cognitive behavioral therapy (CBT)] as an adjunctive therapy in [primary care buprenorphine/naloxone treatment]. The study aimed to assess whether CBT, in addition to physician management (PM), improves treatment outcomes for prescription opioid and heroin use disorder patients.

CBT: A Valuable Tool for Opioid Use Disorder

The study's findings reveal that CBT, when combined with PM, significantly improves treatment outcomes for patients with prescription opioid use disorder. The addition of CBT was associated with a greater number of weeks of abstinence for all drugs, particularly for those with prescription opioid use disorder. These findings highlight the potential of CBT as a valuable tool for enhancing treatment success in primary care settings.

A Path to Recovery: Combining CBT and Buprenorphine

The study's findings suggest that integrating CBT into buprenorphine/naloxone treatment can enhance treatment outcomes for patients with opioid use disorder. This combined approach offers a potential pathway to recovery, empowering individuals to manage their addiction and regain control of their lives.

Dr.Camel's Conclusion

The journey through opioid use disorder can be challenging, but effective treatments are emerging. This study highlights the potential of CBT as a valuable ally in primary care buprenorphine/naloxone treatment, especially for patients with prescription opioid use disorder. This research underscores the importance of personalized approaches and evidence-based therapies in addressing the complexities of opioid addiction.

Date :
  1. Date Completed 2017-12-19
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

27776678

DOI: Digital Object Identifier

NIHMS814533

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.